Status:
COMPLETED
Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants
Lead Sponsor:
Azienda Ospedaliera Universitaria Policlinico
Conditions:
Deep Vein Thrombosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Background. The optimal duration of oral anticoagulant treatment in patients with idiopathic Deep Vein Thrombosis (DVT)of the lower limbs is still uncertain. Residual Vein Thrombosis (RVT) has been fo...
Detailed Description
INTRODUCTION Long-term anticoagulant treatment with adjusted doses of vitamin K antagonists is highly effective in preventing recurrent events after a first episode of unprovoked Venous ThromboEmbolis...
Eligibility Criteria
Inclusion
- First episode of unprovoked proximal DVT of the lower limbs and treated for 3 month with oral anticoagulants
Exclusion
- Active cancer,
- Limited life expectancy,
- Antiphospholipid antibody syndrome, or an other known thrombophilic status (such as antithrombin deficiency),
- Serious liver disease,
- Pregnancy
- Conditions requiring anticoagulation (atrial fibrillation, etc)
Key Trial Info
Start Date :
June 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00623987
Start Date
June 1 1999
End Date
January 1 2008
Last Update
March 25 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sergio Siragusa
Palermo, Italy, 90127